Vitrolife AB (publ) (LON:0YAY)

Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of GBP 1.46 billion. The enterprise value is 1.55 billion.

Market Cap	1.46B
Enterprise Value	1.55B

Important Dates

The next estimated earnings date is Thursday, October 23, 2025.

Earnings Date	Oct 23, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	135.42M
Shares Outstanding	n/a
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	75.04M

Valuation Ratios

The trailing PE ratio is 41.85 and the forward PE ratio is 31.34.

PE Ratio	41.85
Forward PE	31.34
PS Ratio	5.38
PB Ratio	1.43
P/TBV Ratio	n/a
P/FCF Ratio	35.33
P/OCF Ratio	27.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.40, with an EV/FCF ratio of 37.38.

EV / Earnings	44.29
EV / Sales	5.51
EV / EBITDA	17.40
EV / EBIT	28.08
EV / FCF	37.38

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.15.

Current Ratio	3.41
Quick Ratio	2.61
Debt / Equity	0.15
Debt / EBITDA	1.78
Debt / FCF	3.70
Interest Coverage	7.09

Financial Efficiency

Return on equity (ROE) is 3.45% and return on invested capital (ROIC) is 2.85%.

Return on Equity (ROE)	3.45%
Return on Assets (ROA)	2.58%
Return on Invested Capital (ROIC)	2.85%
Return on Capital Employed (ROCE)	4.29%
Revenue Per Employee	236,959
Profits Per Employee	30,448
Employee Count	1,169
Asset Turnover	0.21
Inventory Turnover	3.63

Taxes

In the past 12 months, Vitrolife AB has paid 11.97 million in taxes.

Income Tax	11.97M
Effective Tax Rate	25.53%

Stock Price Statistics

The stock price has decreased by -45.62% in the last 52 weeks. The beta is 1.74, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	-45.62%
50-Day Moving Average	139.69
200-Day Moving Average	170.21
Relative Strength Index (RSI)	45.60
Average Volume (20 Days)	25,447

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of GBP 271.79 million and earned 34.92 million in profits. Earnings per share was 0.26.

Revenue	271.79M
Gross Profit	159.96M
Operating Income	53.35M
Pretax Income	46.90M
Net Income	34.92M
EBITDA	82.36M
EBIT	53.35M
Earnings Per Share (EPS)	0.26

Balance Sheet

The company has 70.69 million in cash and 152.97 million in debt, giving a net cash position of -82.28 million.

Cash & Cash Equivalents	70.69M
Total Debt	152.97M
Net Cash	-82.28M
Net Cash Per Share	n/a
Equity (Book Value)	1.02B
Book Value Per Share	7.53
Working Capital	118.36M

Cash Flow

In the last 12 months, operating cash flow was 53.19 million and capital expenditures -11.82 million, giving a free cash flow of 41.37 million.

Operating Cash Flow	53.19M
Capital Expenditures	-11.82M
Free Cash Flow	41.37M
FCF Per Share	n/a

Margins

Gross margin is 58.85%, with operating and profit margins of 19.63% and 12.85%.

Gross Margin	58.85%
Operating Margin	19.63%
Pretax Margin	17.26%
Profit Margin	12.85%
EBITDA Margin	30.30%
EBIT Margin	19.63%
FCF Margin	15.22%

Dividends & Yields

This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 0.06%.

Dividend Per Share	0.09
Dividend Yield	0.06%
Dividend Growth (YoY)	16.40%
Years of Dividend Growth	2
Payout Ratio	32.75%
Buyback Yield	-0.10%
Shareholder Yield	-0.04%
Earnings Yield	2.39%
FCF Yield	2.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 4.9 and a Piotroski F-Score of 8.

Altman Z-Score	4.9
Piotroski F-Score	8